haku: @indexterm medicine / yhteensä: 97
viitteet: 6-15 / 97
« edellinen sivu | seuraava sivu »
 otsikkovuositekijä
6.
Consumer responses towards non-prescription and prescription drug advertising in the US and Germany
International Journal of Advertising
2008 : VOL. 27:1 p. 99-131
 2008 Diehl, S.
Mueller, B.
Terlutter, R.
7.
Randomized trials of education and medical practices: Strengths and limitations
Economics of innovation and new technology
2007 : JUL-SEP, VOL. 16:5-6, p. 303-306
 2007 Foray, D.
Murnane, R.
Nelson, R. (eds.)
8.
Accounting and medicine: An exploratory investigation into physicians' attitudes toward the use of standard cost-accounting methods in medicine
Journal of Business Ethics
2007 : OCT, VOL. 75:2, p. 137-149
 2007 Thibadoux, G. M.
Scheidt, M.
Luckey, E.
9.
On the will to ignorance in bureaucracy
Economy and Society
2007 : MAY, VOL. 36:2 p. 212-235
 2007 McGoey, L.
10.
Is there a morally right price for anti-retroviral drugs in the developing world?
Business Ethics
2006 : JAN, VOL 15:1, p. 29-43
 2006 Brennan, R.
Baines, P.
11.
Testing drugs on animals: a test case for socially responsible investment
Business Ethics
2005 : APR, VOL 14:2, p. 164-175
 2005 Taylor, R.
12.
International pricing and distribution of therapeutic pharmaceuticals - an ethical minefield
Business Ethics
2005 : APR, VOL 14:2, p. 127-141
 2005 Buckley, J.
Tuama, S. Ó.
13.
A model for addressing stakeholders' concerns about direct-to-consumer advertising of prescription medicines
European Journal of Marketing
2005 : VOL. 39:9-10, p. 1151-1165
 2005 Hoek, J.
Maubach, N.
14.
The challenges for neuroscience in ad research
Admap
2005 : SEP, VOL 40:8, p. 36-38
 2005 Page, G.
15.
Could brain science be peace broker in the 'Recall Wars'?
Admap
2005 : SEP, VOL 40:8, p. 33-35
 2005 Penn, D.
« edellinen sivu | seuraava sivu »
SCIMA